Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...

Core Viewpoint - Axsome Therapeutics has resubmitted its New Drug Application (NDA) for AXS-07 for the acute treatment of migraine, with the FDA setting a PDUFA action goal date of January 31, 2025 [1] Industry Overview - Migraine affects approximately 39 million Americans and is the leading cause of disability among neurological disorders in the U.S. [2] - Over 70% of migraine sufferers express dissatisfaction with current treatments, seeking faster and more consistent relief [2] Company Overview - Axsome Therapeutics is focused on developing novel therapies for central nervous system (CNS) disorders with limited treatment options [4] - The company aims to transform the treatment of CNS conditions through innovative mechanisms of action [4] Product Overview - AXS-07 is an investigational oral medication combining MoSEIC™ meloxicam and rizatriptan, designed for rapid and consistent migraine relief [3] - AXS-07 utilizes MoSEIC technology for enhanced absorption and has over 200 patents protecting its formulation until at least 2038 [3]

Investors looking for stocks in the Insurance - Property and Casualty sector might want to consider either Axis Capital (AXS) or Cincinnati Financial (CINF) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Styl ...

For those looking to find strong Finance stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Axis Capital (AXS) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.Axis Capital is a member of our Finance group, which includes 860 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 ...

A month has gone by since the last earnings report for Axis Capital (AXS) . Shares have added about 3.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Axis Capital due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. AXIS Capital Q2 Earnings Beat on Solid UnderwritingA ...

Shares of AXIS Capital Holdings (AXS) have rallied 38.4% year to date, compared with the industry’s increase of 26.2%, the Finance sector’s rise of 13.4% and the Zacks S&P 500 composite’s rise of 18.2%. With a market capitalization of $2.8 billion, the average volume of shares traded in the last three months was 0.5 million.A compelling and diversified product portfolio, underwriting excellence, digital capabilities and solid capital position continue to drive the Zacks Rank #1 (Strong Buy) specialty and gl ...

The Zacks Insurance industry is undervalued than the Zacks S&P 500 composite and the Zacks Finance sector. The insurance industry’s price-to-book (the best multiple for valuing insurers because of their unpredictable financial results) of 1.57 was less than the Zacks S&P 500 composite’s P/B of 8.57 and the sector’s P/B of 3.65. Such below-market positioning hints at room for an upside in the days ahead.Image Source: Zacks Investment ResearchImage Source: Zacks Investment ResearchThus, before their valuation ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 19th:UCB (UCBJF) : This biopharmaceutical and specialty chemical company that specializes in providing therapy for central nervous system disorders, including epilepsy, diabetic neuropathic pain, sclerosis and Parkinson's disease, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.9% over the last 60 days.UCB’s shares gained 25.5% ...

Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 19th:  Axis Capital Holdings (AXS) : This company which provides a broad range of specialty insurance and reinsurance solutions to its clients on a worldwide basis, carries a Zacks Rank #1(Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.Axis Capital Holdings' has a price-to-earnings ratio (P/E) of 7.03 compared with 15.20 ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Seagate Technology (STX) : This company which is leading provider of data storage technology and infrastructure solutions, has seen the Zacks Consensus Estimate for its current year earnings increasing 30.2% over the last 60 day.Sterling Infrastructure, Inc. (STRL) : This company which operates through subsidiaries within segments specializing in E-Infrastructure, Building and Transportation Solutions principally in the United States, h ...